APA (7th ed.) Citation

S, M., V, F., C, P., O, R., S, D., M, M., . . . B, H. (2025). Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. Communications biology, 8(1), 57. https://doi.org/10.1038/s42003-025-07491-4

Chicago Style (17th ed.) Citation

S, Mougari, et al. "Intranasally Administrated Fusion-inhibitory Lipopeptides Block SARS-CoV-2 Infection in Mice and Enable Long-term Protective Immunity." Communications Biology 8, no. 1 (2025): 57. https://doi.org/10.1038/s42003-025-07491-4.

MLA (9th ed.) Citation

S, Mougari, et al. "Intranasally Administrated Fusion-inhibitory Lipopeptides Block SARS-CoV-2 Infection in Mice and Enable Long-term Protective Immunity." Communications Biology, vol. 8, no. 1, 2025, p. 57, https://doi.org/10.1038/s42003-025-07491-4.